KARL STORZ SE has been granted a patent for a fluorescence diagnosis system featuring a dual semiconductor light source. It includes a spectral filter, brightness control, and an optical intensity attenuator, enabling effective tissue differentiation by managing light emission and enhancing fluorescence detection through a specialized camera setup. GlobalData’s report on KARL STORZ SE gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on KARL STORZ SE, Surgical robots was a key innovation area identified from patents. KARL STORZ SE's grant share as of June 2024 was 69%. Grant share is based on the ratio of number of grants to total number of patents.
Fluorescence diagnosis light source with adjustable intensity control
The granted patent US12042130B2 describes a sophisticated system for fluorescence diagnosis that integrates advanced optical components to enhance tissue differentiation in medical imaging. The system comprises a light source featuring two semiconductor-illuminant based light emission units: one that emits broadband first light for background illumination and another that emits narrowband second light for fluorescence excitation. A camera with multiple color channels captures fluorescence and background images, allowing for effective contrast generation. Key components include a spectral filter to block specific wavelengths, a brightness control to adjust light intensity, and an optical intensity attenuator that further reduces light intensity beyond the brightness control's capabilities. The system is designed to switch between white-light and fluorescence modes, optimizing the imaging process for various diagnostic needs.
Additionally, the patent outlines a method for fluorescence diagnosis that involves emitting light from the two light emission units, detecting fluorescence through the camera, and managing background illumination. The method emphasizes the importance of controlling light intensity, with specific ranges defined for both the brightness control and the optical intensity attenuator. The background illumination is carefully calibrated to ensure optimal imaging conditions, with intensity levels specified to be a fraction of the maximum output. The system's design allows for the integration of various filters and attenuators, enhancing its versatility in clinical applications. Overall, this patent presents a comprehensive approach to improving fluorescence imaging techniques in medical diagnostics.
To know more about GlobalData’s detailed insights on KARL STORZ SE, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
